Comparison of Three Different TTF-1 Clones in Resected Primary Lung Cancer and Epithelial Pulmonary Metastases

Am J Clin Pathol. 2018 Oct 24;150(6):533-544. doi: 10.1093/ajcp/aqy083.

Abstract

Objectives: Immunohistochemical staining against thyroid transcription factor 1 (TTF-1) is often used to distinguish lung adenocarcinoma from squamous cell carcinoma and pulmonary metastasis.

Methods: TTF-1 expression was examined using the antibody clones 8G7G3/1, SPT24, and SP141 on tissue microarrays from 665 cases of resected lung cancers and 428 pulmonary metastases.

Results: Most lung adenocarcinomas, 89%, 93%, and 93%, were positive with TTF-1 clones 8G7G3/1, SPT24, and SP141, respectively. The corresponding figures for lung squamous cell carcinomas were 0%, 6%, and 8%. In total, five (2%), 19 (7%), and 21 (8%) of the pulmonary metastases from colorectal adenocarcinomas were positive with clones 8G7G3/1, SPT24, and SP141, respectively. Other TTF-1-positive pulmonary metastases (n = 8) were thyroid, urothelial, pancreatic, small bowel, and cervix carcinomas.

Conclusions: TTF-1 expression in lung cancer and pulmonary metastases differs between clones, with 8G7G3/1 being more specific but less sensitive compared with SPT24 and SP141.

Publication types

  • Comparative Study

MeSH terms

  • Adenocarcinoma of Lung / diagnosis*
  • Adult
  • Aged
  • Aged, 80 and over
  • Antibodies, Monoclonal*
  • Biomarkers, Tumor / analysis*
  • Carcinoma, Squamous Cell / diagnosis
  • Diagnosis, Differential
  • Female
  • Humans
  • Lung Neoplasms / diagnosis*
  • Male
  • Middle Aged
  • Neoplasm Metastasis / diagnosis*
  • Retrospective Studies
  • Sensitivity and Specificity
  • Thyroid Nuclear Factor 1 / analysis*

Substances

  • Antibodies, Monoclonal
  • Biomarkers, Tumor
  • Thyroid Nuclear Factor 1